Chemical Information
Antiviral agent ID	DrugRepV_3753
Antiviral agent name	MLS000534476
IUPAC Name	3-(2-aminoethylamino)-1-phenyl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile
SMILES (canonical)	C1CCC2=C(N=C(C(=C2C1)C#N)NCCN)C3=CC=CC=C3
Molecular Formula	C18H20N4
Molecular Weight (g/mol)	292.386
InChl	InChI=1S/C18H20N4/c19-10-11-21-18-16(12-20)14-8-4-5-9-15(14)17(22-18)13-6-2-1-3-7-13/h1-3,6-7H,4-5,8-11,19H2,(H,21,22)
Synonyms	SMR000141912 | AC1M4VYM | BDBM55403
Structural Information
Clinical Information
Biological Information
Secondary Indication	Marburg virus (MARV) NA Musoke
Secondary Indication (Approaches)	Experimental
Secondary Indication (Methods)	In-vitro
Secondary Indication (Model system) [cell lines/ animal models]	HeLa
Secondary Indication (Viral titer)	0.075 to 0.15 MOI
Secondary Indication (Mode of drug delivery)	Culture
Secondary Indication (Duration of drug delivery)	24 hours
Secondary Indication (Drug concentration)	6.2 ± 0.5 μM
Secondary Indication (Change)	Decrease
Secondary Indication (Type of Inhibition)	IC50 [ 50 % ]
Secondary Indication (Cytotoxicity)	>50 μM
Reference	Anantpadma M, Kouznetsova J, Wang H, Huang R, Kolokoltsov A, Guha R, Lindstrom AR, Shtanko O, Simeonov A, Maloney DJ, Maury W, LaCount DJ, Jadhav A, Davey RA..Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors..Antimicrob Agents Chemother. 2016 Jul 22;60(8):4471-81. doi: 10.1128/AAC.00543-16. Print 2016 Aug. P PMID:27161622
Comment	Each compound blocked infection of primary human macrophages, indicating their potential to be developed as new antifiloviral therapies.